Entrada Therapeuticsの空売り状況は、投資家がEntrada Therapeuticsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Entrada Therapeutics (NASDAQ:TRDA) 株価情報, 空売り情報

Entrada Therapeutics

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics Inc

WIIM

Clearwater Paper shares are trading higher. The company reported Q1 financial results.

BMO Capital analyst John McNulty maintains LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) with a Market Perform and lowers the price target from $71 to $65.

News

Price Target

Analyst Ratings

BMO Capital Maintains Market Perform on LyondellBasell Industries, Lowers Price Target to $65

JMP Securities analyst Silvan Tuerkcan reiterates Foghorn Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FHTX#NASDAQ">FHTX</a>) with a Market Outperform and maintains $9 price target.

Reiteration

FHTX

JMP Securities Reiterates Market Outperform on Foghorn Therapeutics, Maintains $9 Price Target

Bluelinx Holdings shares are trading lower after the company reported worse-than-expected Q1 sales results.

<a href="https://www.bloomberg.com/news/articles/2025-04-30/nvidia-ceo-says-trump-should-revise-rules-for-ai-chip-exports">https://www.bloomberg.com/news/articles/2025-04-30/nvidia-ceo-says-trump-should-revise-rules-for-ai-chip-exports</a>

Politics

Economics

General

NVDA

'Nvidia CEO Says Trump Should Revise Rules for AI Chip Exports'- Bloomberg

UBS analyst Damian Karas maintains Zebra Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) with a Buy and lowers the price target from $425 to $410.

ZBRA

UBS Maintains Buy on Zebra Technologies, Lowers Price Target to $410

Cash dividend payable in the second quarter of 2025
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.amwater.com%2F&amp;esheet=54244979&amp;newsitemid=20250428924695&amp;lan=en-US&amp;anchor=American+Water+Works+Company%2C+Inc.&amp;index=1&amp;md5=26c87ab3685f4eb734cbb8ecf74fd0ca">American Water Works Company, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>) announced that its board of directors today declared a quarterly cash dividend payment of $0.8275 per share of common stock, an increase of 8.2 percent.
The company expects to continue its dividend growth within a 7 to 9 percent range over the long term, with a target dividend payout ratio of between 55 and 60 percent of earnings.
The increased quarterly dividend will be payable on June 3, 2025, to all shareholders of record as of May 13, 2025.
 &nbsp;

Dividends

American Water Works Hikes Quarterly Cash Dividend By 8.2% To $0.8275/Shr

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/30130214/Linklogis-0430-900x600-1.png" alt="" class="wp-image-11927" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/30130214/Linklogis-0430-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/30130214/Linklogis-0430-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/30130214/Linklogis-0430-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
Transactions on the company's supply chain financing platforms grew just 7% in the first quarter as it failed to reduce its reliance on property-related customers
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul>
<li>Transactions on Linklogis' platforms increased just 7% in the first quarter, far slower than the 45% rise in the first quarter of 2024 and 28% for all last year</li>
<li>The company has been trying to reduce its reliance on real estate-related sectors, such as infrastructure and construction, but it isn't making much headway</li>
</ul>
Linklogis Inc.&nbsp;(9959.HK) appears to be hitting a wall in its attempts to extricate itself from the shadows of China's prolonged real estate downturn.
The company has been one of the many casualties of that long-running slump due to its heavy reliance on customers from related sectors like infrastructure and construction for its cloud-based supply chain financing services. With no end to the property downturn in sight, the company has been trying to expand its customer base into other sectors. But its first-quarter&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0425/2025042501575.pdf">business update</a>&nbsp;released last week shows it isn't making much headway.
That's somewhat understandable. In the current shaky economic environment, Linklogis can't simply chase any potential customers just to speed up its growth and diversification, since it still needs to find high-quality users that will meet their payment obligations.
That means the company, like many other financiers, needs to walk a fine line between growing its business and managing risks. Perhaps reflecting its struggle to balance those two, the total volume of transactions on its platforms increased just 7% to 100 billion yuan ($13.7 billion) in the first quarter from the year-earlier period. That's a sharp slowdown from 45% year-on-year growth in the first quarter of 2024, as well as 28% growth for all last year.
In supply chain financing, a company, sometimes called an "anchor," uses unpaid bills it owes to its suppliers to help them obtain financing, leveraging its own creditworthiness to benefit its suppliers. Both the anchor and suppliers benefit because the former gets more time to pay its bills, while the latter can get cash to finance their operations. Linklogis' platforms are designed to make supply chain financing easier for all involved parties by digitalizing everything from management of underlying assets to securitization.
Supply chain financing in China has grown fast in recent years, partly because of a general shortage of credit available to small and medium-sized enterprises (SMEs) from traditional banks. But when times are rough, like now, this corner of the financing universe can feel the pinch too, as Linklogis is showing.&nbsp;&nbsp;
The company's overall transaction volume would have shrunk in the first quarter, if not for its "Multi-tier Transfer Cloud" product, which saw a 37% rise in transaction volume to single-handedly outweigh decreases for other services, including "AMS Cloud" and "ABS Cloud." In Linklogis' latest business update, CEO Charles Song attributed the contraction of transactions on the other platforms to "subdued" market sentiment and delays in issuance of asset-backed securities (ABS).
<h4 class="wp-block-heading">Slow revenue growth</h4>
Linklogis' revenue growth in the first quarter probably lagged the uninspired 7% increase in its transaction volume and may have even fallen, given that its fees are under pressure. It didn't provide an actual revenue figure in the first-quarter update. But last year, the company's 19% revenue growth for the year trailed its 28% growth in transaction volume.
Specifically, fees for the company's Multi-tier Transfer Cloud platform seem lower than those for AMS Cloud and ABS Cloud, considering that the rapid transaction growth of Multi-tier Cloud isn't translating into proportionate revenue gains. Multi-tier Transfer Cloud is a relatively new product for Linklogis, but it has already become the company's mainstay. The service converts receivables from transactions between small and medium-sized enterprises (SMEs) and their customers into digital payment obligations (Digipos) through the use of blockchain technology.
Multi-tier Transfer Cloud overtook AMS Cloud as Linklogis' biggest product in terms of transaction volume only in 2022, and has grown exponentially since then. The volume of transactions on Multi-tier Transfer Cloud surged 82% in 2023, and grew another 52% last year. But Linklogis' revenue from its main supply financing services actually declined in 2023 and increased only about 18% last year.
The company's customer acquisition has also slowed, which suggests that it's having some difficulty finding new users for its products, particularly outside real estate-related sectors. For example, the total number of its anchor enterprise partners, its largest customer group, increased 45% last year, while it almost doubled as recently as 2021.
Meanwhile, Linklogis' dependence on property-related customers deepened last year, even though such clients have probably become riskier and thus are less desirable due to the market's ongoing woes. The proportion of infrastructure and construction, and real estate sectors in Linklogis' total transaction volume increased to a combined 51% last year from 44% in 2023 and 48% in 2022. This means that many of the company's newly acquired customers are from those sectors, or that existing customers from those areas became more active on Linklogis' platforms. Neither possibility looks ideal for Linklogis, given the gloom over China's property market.
Reflecting heightened stress among the company's customers, its impairment losses almost tripled last year, erasing most of its gross profit. As a result, its net loss swelled, even though its revenue grew.
Although Linklogis is essentially a platform operator, it does face some liability when its customers fail to pay their bills. This is because the company collects supply chain assets like unpaid bills that can be securitized, and then carries them on its own balance sheet temporarily for certain periods, a process known as "warehousing." If a company defaults on its bills during a warehousing period, Linklogis must swallow any resulting losses in the form of impairment costs.
Shares of Linklogis, which is backed by internet giant Tencent, have lost more than 90% of their value since the company's IPO in 2021, including a 31% decline this year alone, to trade at a modest price-to-sale (P/S) ratio of 2. That said, valuations are also depressed for other online financiers such as&nbsp;FinVolution Group&nbsp;(FINV.US), which is profitable and yet has a P/S ratio of just 1. This shows how investors are cautious on this group of companies due to their exposure to vulnerabilities in China's current weak economy.
That means Linklogis still has a long way to go to win over investors.

Asia

Opinion

Real Estate

Lingering In The Shadows of China's Prolonged Real Estate Downturn

MDLZ

Mondelez International shares are trading higher after Morgan Stanley raised its price target on the stock from $69 to $62 and maintained an Overweight rating.

BMO Capital analyst Ameet Thakkar maintains First Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) with a Outperform and lowers the price target from $200 to $187.

FSLR

BMO Capital Maintains Outperform on First Solar, Lowers Price Target to $187

PYPL

PayPal shares are trading lower after UBS cut its price target on the stock from $88 to $75.

Nike shares are trading lower after Wells Fargo downgraded the stock from Overweight to Equal-Weight and cut its price target from $75 to $55.

UBS analyst Timothy Chiodo maintains Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) with a Buy and lowers the price target from $400 to $395.

UBS Maintains Buy on Visa, Lowers Price Target to $395

INTC

Intel shares are trading lower after Seaport Global initiated coverage on the stock with a Sell rating and announced a price target of $18. Additionally, Rosenblatt maintained a Sell rating on the stock.

BMO Capital analyst Rufus Hone maintains Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) with a Outperform and raises the price target from $370 to $380.

BMO Capital Maintains Outperform on Visa, Raises Price Target to $380

Jones Lang LaSalle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JLL#NYSE">JLL</a>) has outperformed the market over the past 5 years by 3.17% on an annualized basis producing an average annual return of 16.98%. Currently, Jones Lang LaSalle has a market capitalization of $10.85 billion. 
Buying $1000 In JLL: If an investor had bought $1000 of JLL stock 5 years ago, it would be worth $2,219.84 today based on a price of $228.40 for JLL at the time of writing.
<h3>Jones Lang LaSalle's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746024312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Jones Lang LaSalle 5 Years Ago Would Be Worth This Much Today

UBS analyst Thomas Wadewitz maintains TFI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFII#NYSE">TFII</a>) with a Neutral and lowers the price target from $107 to $88.

TFII

UBS Maintains Neutral on TFI International, Lowers Price Target to $88

Macro Economic Events

Global

STLA

TSLA

Watching Shares Of Automakers; Reuters Reports Mexico President Reportedly Says U.S. Easing Of Tariffs On The Auto Sector Is A Step Forward, A Recognition Of The North American Trade Agreement

BMO Capital analyst James Thalacker maintains Entergy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETR#NYSE">ETR</a>) with a Outperform and raises the price target from $89 to $93.

BMO Capital Maintains Outperform on Entergy, Raises Price Target to $93

UBS analyst Roger Boyd maintains Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Buy and lowers the price target from $47 to $40.

TENB

UBS Maintains Buy on Tenable Holdings, Lowers Price Target to $40

Press Releases

āshibio Announces Appointment of Dipal Doshi, CEO of Entrada Therapeutics, to its Board of Directors

Management

Entrada Therapeutics Promotes Natarajan Sethuraman, PhD, to President of Research and Development

Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society

Earnings

Entrada Therapeutics Reports Third Quarter 2024 Financial Results

Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Azenta Announces the Election of Dipal Doshi to its Board of Directors

Health Care

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-44-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-44 in Patients Living with Duchenne Muscular Dystrophy

Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44

Entrada Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in People Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping

Comments

Entrada Therapeutics

空売り

Entrada Therapeutics (NASDAQ:TRDA) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル